The MedApps “Healthcare Anywhere” System is an ideal solution for disease management organizations (DMOs) and co-morbidity patients. It provides the ability to connect more patients to healthcare providers, central nursing call centers and health care partners at a significant cost reduction, compared to the Telemedicine 1.0 solutions currently in place today.

Millions of patients are under disease management (DM) care in the US today. DM objectives are two-fold; first, to lengthen patients' lives while increasing quality of life, and second, decrease health care costs. Wireless remote monitoring addresses both goals and represents a total US market of more than 60 million people who suffer from one or more chronic diseases. DMOs will be a primary focus for MedApps, as they are a driving force to buy and operate MedApps services. In turn the DMOs operating costs are reduced, profitability will increase and better care will be provided to patients.

The MedApps System offers many benefits to the private practitioner, the medical investigation market, private nursing homes and other medical facilities, and can play an important role in pilot studies and clinical trials. It is the perfect solution for the future development of specialized nursing centers that will focus on specialized disease care throughout the U.S.

MedApps' goal is to make sure their product costs remain low. MedApps feels that in order to compete in the consumer market / retail market, developing $1000 devices for homecare consumers will not help.MedApps is developing its interface wireless products in order to integrate with medical devices that are less than $100, thus being competitive, and giving the market what it needs.
The MedApps model is to create invisible technology that interfaces to off-the-shelf medical devices and not create new devices that require new payment methods and new distribution channels, which restrict the entry of new telemedicine devices into the market.